Investments
10Portfolio Exits
2Latest Initiative Capital Romandie News
Apr 8, 2013
Endosense (Switzerland), a commercial-stage medical device company focused on catheter ablation for cardiac arrhythmias, closed a $40.3M Series C financing. Participants included NGN Capital , Edmond de Rothschild Investment Partners , NeoMed Management , Gimv , VI Partners , Sectoral Asset Management , Ysios Capital Partners and Initiative Capital Romandie .
Initiative Capital Romandie Investments
10 Investments
Initiative Capital Romandie has made 10 investments. Their latest investment was in Aleva Neurotherapeutics as part of their Series D on October 10, 2017.
Initiative Capital Romandie Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/4/2017 | Series D | Aleva Neurotherapeutics | $13M | No | 1 | |
5/27/2016 | Series C | Aleva Neurotherapeutics | $18M | Yes | 5 | |
6/7/2013 | Series B - II | Diagnoplex | $1.39M | Yes | 1 | |
3/5/2013 | Series C - II | |||||
11/27/2012 | Series C |
Date | 10/4/2017 | 5/27/2016 | 6/7/2013 | 3/5/2013 | 11/27/2012 |
|---|---|---|---|---|---|
Round | Series D | Series C | Series B - II | Series C - II | Series C |
Company | Aleva Neurotherapeutics | Aleva Neurotherapeutics | Diagnoplex | ||
Amount | $13M | $18M | $1.39M | ||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 1 | 5 | 1 |
Initiative Capital Romandie Portfolio Exits
2 Portfolio Exits
Initiative Capital Romandie has 2 portfolio exits. Their latest portfolio exit was Endosense on August 19, 2013.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/19/2013 | Acquired | 1 | |||
Date | 8/19/2013 | |
|---|---|---|
Exit | Acquired | |
Companies | ||
Valuation | ||
Acquirer | ||
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.